Evidence mapPaperPMID 31209855Full record

ArticleThe British journal of dermatology2020

Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis.

A Green, G Shaddick, R Charlton, J Snowball, A Nightingale, C Smith, W Tillett, N McHugh, PROMPT study group

Registry-linked trialOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in The British journal of dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07443956 (Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis), which is not on this map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07443956 narecruitingstarted 2026, after this paper: background citation

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

Ran2026Enrolled45Registered outcomes5Posted comparisons0ConditionsObesity & Overweight, Psoriatic Arthritis (PsA)ArmsIxekizumab, Tirzepatide
Open the trial in the graph
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis.The Journal of international medical research · 2020
    Pooled it
  5. Trial
  6. Lifestyle Modification for the Management of Psoriatic Arthritis.American journal of lifestyle medicine · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

A GreenDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.ORCID 0000-0002-7246-2074
G ShaddickDepartment of Mathematics, University of Exeter, Exeter, U.K.
R CharltonDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.
J SnowballDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.
A NightingaleDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.
C SmithSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, U.K.ORCID 0000-0003-1895-6070
W TillettDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.
N McHughDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.
PROMPT study group
University of Bath · GBRoyal National Hospital for Rheumatic Diseases · GBGuy's and St Thomas' NHS Foundation Trust · GBUniversity of Exeter · GB

Funding

Department of Health RP-PG-1212-20007National Institute for Health Research RP-PG-1212-20007
6 · The paper itself

Abstract

backgroundPsoriatic arthritis (PsA) is a progressive and often destructive joint disease affecting approximately 20% of people with psoriasis.

objectivesTo investigate associations between obesity, changes in body mass index (BMI), alcohol intake and smoking status and the development of PsA in people with psoriasis.

methodsWe undertook a cohort study involving incident cases of psoriasis identified from the U.K. Clinical Practice Research Datalink between 1998 and 2014. The associations between smoking, alcohol and BMI and development of PsA were assessed using generalized additive models. Additionally, the risks associated with a change in BMI during follow-up were investigated using distributed lag nonlinear models.

resultsWe identified 90 189 incident cases of psoriasis (42% male, mean age 51 years), of whom 1409 had a subsequent record of PsA diagnosis. BMIs of 25·0-29·9, 30·0-34·9 and ≥ 35·0 kg m

conclusionsIn this incident psoriasis cohort, increased BMI and moderate drinking, but not heavy drinking or smoking status, were associated with an increased risk of PsA in people with psoriasis. Importantly, we have shown that reducing weight may result in a reduction in the risk of developing PsA. What's already known about this topic? There is some evidence that increased body mass index is associated with an increased risk of developing psoriatic arthritis. There are conflicting results surrounding the relationship between smoking and the development of psoriatic arthritis among patients with psoriasis. What does this study add? Using a nonlinear and lagged effect of body mass index measured over time we have shown that reducing body mass index may be associated with a reduction in the risk of developing psoriatic arthritis. We have found no evidence that smoking alters the risk of developing psoriatic arthritis in patients with psoriasis.

Indexed as

Arthritis, PsoriaticPsoriasisCohort StudiesFemaleHumansIncidenceMaleMiddle AgedRisk Factors

Identifiers

PMID31209855
OpenAlexW2952072577

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.